Quality of Life Evaluation in Saudi Arabian Pediatric Patients with Primary Immunodeficiency Diseases Receiving 20% Subcutaneous IgG Infusions at Home

被引：0
|
作者：
Bandar Al-Saud
Nora AlRumayyan
Areej Alfattani
Sawsan Abu Awwad
Dema Al Saud
Reem Mohammed
Sultan Albuhairi
Sahar Elshorbagi
Sakra S. Balhareth
Hasan Al-Dhekri
Rand Arnaout
Edward B. De Vol
Hamoud Al-Mousa
机构：
[1] King Faisal Specialist Hospital & Research Center,Section of Pediatric Allergy/Immunology, Department of Pediatrics
[2] Alfaisal University,College of Medicine
[3] King Faisal Specialist Hospital & Research Centre,Biostatistics, Epidemiology and Scientific Computing Department
[4] King Faisal Specialist Hospital & Research Center,Nursing affairs
[5] King Faisal Specialist Hospital & Research Center,Pharmaceutical Care Division
来源：
Journal of Clinical Immunology | 2023年 / 43卷
关键词：
Immunoglobulin replacement therapy; intravenous immunoglobulin; primary antibody deficiency; hypogammaglobinemia; severe combined immunodeficiency;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1360 / 1366
页数：6
相关论文
共 50 条
  • [31] Quality of Life Differences for Primary Immunodeficiency Patients on Home SCIG versus IVIG
    Christine Anterasian
    Richard Duong
    Peg Gruenemeier
    Carol Ernst
    Jessica Kitsen
    Bob Geng
    Journal of Clinical Immunology, 2019, 39 : 814 - 822
  • [32] Safety and Efficacy of Home-Based Subcutaneous Immunoglobulin G in Elderly Patients with Primary Immunodeficiency Diseases
    Stein, Mark R.
    Koterba, Alan
    Rodden, Linda
    Berger, Melvin
    POSTGRADUATE MEDICINE, 2011, 123 (05) : 186 - 193
  • [33] Distribution and Quality of Life in Patients With Primary Immunodeficiency Diseases in a Cohort of Korean Adults
    Kim, Joo-Hee
    Ye, Young-Min
    Lee, So-Hee
    Ban, Ga-Young
    Nam, Young-Hee
    Choi, Jeong-Hee
    Hur, Gyu-Young
    Cho, You Sook
    Park, Hae-Sim
    ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2021, 13 (01) : 164 - 166
  • [34] Efficacy, Safety, Tolerability, and Serum IgG Trough Levels of Hyaluronidase-Facilitated Subcutaneous Immunoglobulin 10% in US Pediatric Patients with Primary Immunodeficiency Diseases
    Patel, Niraj C.
    Walter, Jolan E.
    Wasserman, Richard L.
    Rubinstein, Arye
    Kankirawatana, Suthida
    Shepherd, Meagan W.
    Greco, Erin
    Li, Zhaoyang
    Russo-Schwarzbaum, Sharon
    Saeed-Khawaja, Shumyla
    Mccoy, Barbara
    Yel, Leman
    JOURNAL OF CLINICAL IMMUNOLOGY, 2025, 45 (01)
  • [35] Efficacy and Safety of Hizentra®, a New 20% Immunoglobulin Preparation for Subcutaneous Administration, in Pediatric Patients with Primary Immunodeficiency
    Michael Borte
    Malgorzata Pac
    Margit Serban
    Teresa Gonzalez-Quevedo
    Bodo Grimbacher
    Stephen Jolles
    Othmar Zenker
    Jutta Neufang-Hueber
    Bernd Belohradsky
    Journal of Clinical Immunology, 2011, 31 : 752 - 761
  • [36] Efficacy and Safety of Hizentra®, a New 20% Immunoglobulin Preparation for Subcutaneous Administration, in Pediatric Patients with Primary Immunodeficiency
    Borte, Michael
    Pac, Malgorzata
    Serban, Margit
    Gonzalez-Quevedo, Teresa
    Grimbacher, Bodo
    Jolles, Stephen
    Zenker, Othmar
    Neufang-Hueber, Jutta
    Belohradsky, Bernd
    JOURNAL OF CLINICAL IMMUNOLOGY, 2011, 31 (05) : 752 - 761
  • [37] Quality of life in common variable immunodeficiency patients treated with 20% subcutaneous immunoglobulin (SCIg) - Hizentra®
    Morariu, R. M.
    Pedini, V
    Marinangeli, L.
    Gelardi, C.
    Savore, I
    Paolini, L.
    Cardinaletti, P.
    Danieli, M. G.
    ALLERGY, 2015, 70 : 369 - 369
  • [38] TREATMENT PREFERENCE AMONG PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASES (PIDD) ON INVESTIGATIONAL 20% SUBCUTANEOUS IMMUNOGLOBULIN THERAPY
    Berner, T.
    Meckley, L.
    Yel, L.
    Engl, W.
    Ito, D.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2016, 117 (05) : S98 - S99
  • [39] Erratum to: Efficacy and Safety of IgPro20, a Subcutaneous Immunoglobulin, in Japanese Patients with Primary Immunodeficiency Diseases
    Hirokazu Kanegane
    Kohsuke Imai
    Masafumi Yamada
    Hidetoshi Takada
    Tadashi Ariga
    Martin Bexon
    Mikhail Rojavin
    Wilson Hu
    Midori Kobayashi
    John-Philip Lawo
    Shigeaki Nonoyama
    Toshiro Hara
    Toshio Miyawaki
    Journal of Clinical Immunology, 2014, 34 : 520 - 520
  • [40] AN EVALUATION OF THE BUDGET IMPACT OF THE NEW 20% SUBCUTANEOUS IMMUNOGLOBULIN (IG20GLY) FOR THE MANAGEMENT OF PRIMARY IMMUNODEFICIENCY DISEASES IN SWITZERLAND
    Pollock, R. F.
    Meckley, L. M.
    VALUE IN HEALTH, 2017, 20 (09) : A549 - A549
12345